Genomics Market Size, Share, Growth, Trends, Forecast, Industry Analysis,
Segmentation | Valuates Reports
The global genomics market size was valued at USD 20.1 billion in 2020 and is expected to expand
at a compound annual growth rate (CAGR) of 15.35% from 2021 to 2028. The scientific community
has tried to address genetic susceptibility and severity to SARS-CoV-2 infection by combining
research efforts using existing genetic databases. Multiomic-based approaches and genome-wide
association studies (GWAS) have been employed to uncover biological networks and common
variants underlying host-pathogen interactions. Similarly, data derived from genomes, such as
polygenic risk scores (PRS), ABO blood groups, and HLA haplotypes, can be potentially used to
decipher COVID-19 complications, resistance, and susceptibility.
In addition, the company has partnered with the Government of Iceland to conduct genome
sequencing of viral hosts. Similarly, the government of Greece funded the COVID-19-GR initiative
to genotype 3,500 COVID-19 patients, conduct WGS on the SARS-CoV-2 genome obtained from
these patients, and conduct immunogenomic analyses. The complete set of this data along with
detailed clinical information is available and can be retrieved from the Greek COVID-19 registry.
To identify the key drivers and the competitors’ insights, Request a Sample @:
In the near future, prenatal genetic screening programs are likely to grow at a significant pace. This is
because these programs help expectant mothers identify chromosomal anomalies in their offspring.
Moreover, it is anticipated that in the next 10 years, every newborn’s genome would be sequenced
and stored in the electronic medical record. Gauging the future market potential of genomics in
newborn screening programs, emerging companies like Counsyl and Natera have launched various
genetic tests to maintain their competitive edge in the market.
Key Player Mentioned: